Operating Income (Loss) in GBP of TC BioPharm (Holdings) plc from 2022 to 2024

Taxonomy & unit
us-gaap: GBP
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
TC BioPharm (Holdings) plc quarterly/annual Operating Income (Loss) history and change rate from 2022 to 2024.
  • TC BioPharm (Holdings) plc Operating Income (Loss) for the quarter ending March 31, 2024 was -£3.44M, a 17.4% increase year-over-year.
  • TC BioPharm (Holdings) plc annual Operating Income (Loss) for 2024 was -£12.8M, a 10.3% increase from 2023.
  • TC BioPharm (Holdings) plc annual Operating Income (Loss) for 2023 was -£14.2M, a 17.8% decline from 2022.
Operating Income (Loss), Quarterly (GBP)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (GBP)
Operating Income (Loss), YoY Annual Change (%)

TC BioPharm (Holdings) plc Quarterly Operating Income (Loss) (GBP)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -3.44M +724K +17.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 -4.17M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15

TC BioPharm (Holdings) plc Annual Operating Income (Loss) (GBP)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -12.8M +1.47M +10.3% Jan 1, 2024 Dec 31, 2024 20-F 2025-05-09
2023 -14.2M -2.16M -17.8% Jan 1, 2023 Dec 31, 2023 20-F 2025-05-09
2022 -12.1M Jan 1, 2022 Dec 31, 2022 20-F 2025-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.